Publication | Closed Access

Development and Preclinical Evaluation of 99mTc- and 186Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors

Drug Targeting186Re-labeled NotaPreclinical EvaluationMedicineAnti-cancer AgentCancer TreatmentRadiation OncologyOncologyCell BiologyCancer ResearchTumor BiologyGrpr-expressing Tumors